tiprankstipranks
Trending News
More News >
PMGC Holdings (ELAB)
NASDAQ:ELAB
US Market

PMGC Holdings (ELAB) Price & Analysis

Compare
303 Followers

ELAB Stock Chart & Stats

$1.55
-$0.19(-8.12%)
At close: 4:00 PM EST
$1.55
-$0.19(-8.12%)

PMGC Holdings News

ELAB FAQ

What was PMGC Holdings’s price range in the past 12 months?
PMGC Holdings lowest stock price was $3.10 and its highest was $398.86 in the past 12 months.
    What is PMGC Holdings’s market cap?
    PMGC Holdings’s market cap is $3.77M.
      When is PMGC Holdings’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were PMGC Holdings’s earnings last quarter?
      Currently, no data Available
      Is PMGC Holdings overvalued?
      According to Wall Street analysts PMGC Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does PMGC Holdings pay dividends?
        PMGC Holdings does not currently pay dividends.
        What is PMGC Holdings’s EPS estimate?
        PMGC Holdings’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does PMGC Holdings have?
        PMGC Holdings has 1,185,795 shares outstanding.
          What happened to PMGC Holdings’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of PMGC Holdings?
          Currently, no hedge funds are holding shares in ELAB
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            PMGC Holdings

            PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operates investment firms. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.

            PMGC Holdings (ELAB) Earnings & Revenues

            Similar Stocks
            Company
            Price & Change
            Follow
            Biodexa Pharmaceuticals
            Indaptus Therapeutics
            InMed Pharmaceuticals
            CNS Pharmaceuticals
            Popular Stocks